BRO Quote, Financials, Valuation and Earnings

CorVel has a net margin of 23.9% compared to Brown & Brown's net margin of 11.41%. Brown & Brown's return on equity of 16.34% beat CorVel's return on equity of 33.58%.

Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 5.25%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Brown & Brown has higher upside potential than CorVel, analysts believe Brown & Brown is more attractive than CorVel.

Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison CorVel has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.958%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.52%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than CorVel quarterly revenues of $231.5M. Brown & Brown's net income of $331M is higher than CorVel's net income of $26.4M. Notably, Brown & Brown's price-to-earnings ratio is 31.36x while CorVel's PE ratio is 60.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.66x versus 6.49x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 23.9% compared to Brown & Brown's net margin of 1.72%. Brown & Brown's return on equity of 16.34% beat eHealth's return on equity of 4.17%.

Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 5.25%. On the other hand eHealth has an analysts' consensus of $10.00 which suggests that it could grow by 128.83%. Given that eHealth has higher upside potential than Brown & Brown, analysts believe eHealth is more attractive than Brown & Brown.

Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison eHealth has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.531%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.52%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than eHealth quarterly revenues of $113.1M. Brown & Brown's net income of $331M is higher than eHealth's net income of $2M. Notably, Brown & Brown's price-to-earnings ratio is 31.36x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.66x versus 0.23x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 7.69%. Brown & Brown's return on equity of 16.34% beat Kingstone Companies's return on equity of 36.5%.

Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 5.25%. On the other hand Kingstone Companies has an analysts' consensus of $22.00 which suggests that it could grow by 39.86%. Given that Kingstone Companies has higher upside potential than Brown & Brown, analysts believe Kingstone Companies is more attractive than Brown & Brown.

Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.731%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.52%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than Kingstone Companies quarterly revenues of $50.5M. Brown & Brown's net income of $331M is higher than Kingstone Companies's net income of $3.9M. Notably, Brown & Brown's price-to-earnings ratio is 31.36x while Kingstone Companies's PE ratio is 9.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.66x versus 1.20x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 19.56%. Brown & Brown's return on equity of 16.34% beat Marsh & McLennan Companies's return on equity of 29.77%.

Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 5.25%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $233.22 which suggests that it could fall by -0.7%. Given that Brown & Brown has higher upside potential than Marsh & McLennan Companies, analysts believe Brown & Brown is more attractive than Marsh & McLennan Companies.

Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.827, suggesting its less volatile than the S&P 500 by 17.269%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.52%. Marsh & McLennan Companies offers a yield of 1.39% to investors and pays a quarterly dividend of $0.82 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are smaller than Marsh & McLennan Companies quarterly revenues of $7.1B. Brown & Brown's net income of $331M is lower than Marsh & McLennan Companies's net income of $1.4B. Notably, Brown & Brown's price-to-earnings ratio is 31.36x while Marsh & McLennan Companies's PE ratio is 28.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.66x versus 4.65x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.